GLP-1 Receptor Agonists Linked to Higher Remission in Ulcerative Colitis: Study

Researchers have found in a retrospective cohort study of patients with ulcerative colitis that treatment with liraglutide or semaglutide was associated with higher remission rates at 12 weeks...
Read the full report on Business Medical Dialogues
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Business Medical Dialogues
- Reporter
- dr riya dave
- Published
- Tuesday, 27 October 2026, 7:00 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

